INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 05,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 668
KIDNEY STRUCTURAL AND FUNCTIONAL CHANGES IN EXPERIMENTAL
ULCERATIVE COLITIS: MORPHOLOGICAL AND MORPHOMETRIC
PERSPECTIVES
Kaymanova Kamila Imamovna
Bukhara state medical institute
https://orcid.org/0009-0004-7738-6578
Abstract:
Ulcerative colitis (UC), a chronic inflammatory bowel disease, is primarily known
for affecting the colonic mucosa; however, accumulating evidence points to significant extra-
intestinal manifestations, including renal involvement. Experimental models of UC,
particularly those induced by dextran sulfate sodium (DSS) and trinitrobenzene sulfonic acid
(TNBS), have revealed notable morphological and morphometric alterations in kidney
structure and function. These include glomerular hypertrophy or atrophy, interstitial fibrosis,
tubular degeneration, and changes in renal volume and architecture. The underlying
mechanisms are multifactorial and involve systemic inflammation, oxidative stress, immune-
mediated injury, and renal ischemia. Morphometric analyses in these models serve as
valuable tools to quantify kidney damage and correlate it with disease severity.
Understanding the renal implications of UC is crucial for early diagnosis, prevention of long-
term kidney complications, and development of targeted therapeutic strategies. This review
consolidates current findings on morphological and morphometric kidney changes in
experimental UC, highlighting both histopathological insights and potential clinical relevance.
Keywords:
Ulcerative colitis; kidney; renal morphology; morphometry; experimental colitis;
DSS model; TNBS model; glomerular damage; interstitial fibrosis; oxidative stress; systemic
inflammation; renal dysfunction; animal models; extra-intestinal manifestations.
Introduction
. Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD)
that primarily affects the colon and rectum. However, UC has been associated with various
extra-intestinal manifestations, including renal dysfunction. While the gastrointestinal tract is
the primary target, studies have increasingly noted changes in renal morphology and function
in patients with UC. Animal models of UC, particularly those induced in laboratory settings,
have provided valuable insights into these renal alterations. The pathophysiological
mechanisms that link UC to kidney involvement remain an area of active research, and
various studies have demonstrated both morphological and morphometric changes in the
kidneys in experimental models of UC.
This review focuses on the available literature concerning the changes in kidney
structure and function in experimental ulcerative colitis models, highlighting key findings
and providing insight into potential mechanisms behind these alterations.
The systemic inflammation observed in UC patients is believed to be a major
contributor to renal pathology. Pro-inflammatory cytokines, such as tumor necrosis factor-
alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6), which are elevated during UC
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 05,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 669
flare-ups, can reach distant organs, including the kidneys, through the bloodstream (Torres et
al., 2017). The kidneys, being highly vascular organs, are particularly susceptible to these
systemic inflammatory signals.
Moreover, UC-related renal abnormalities extend beyond inflammation alone. In
experimental models, renal changes can range from glomerular damage, interstitial fibrosis,
and tubular alterations to altered kidney size and function (Iglesias et al., 2020). Renal
fibrosis, a key feature of chronic kidney disease (CKD), has been observed in UC-induced
models, often as a result of the inflammatory cascade and oxidative stress (Sleiman et al.,
2017). These structural changes can lead to kidney dysfunction, manifesting as proteinuria,
impaired glomerular filtration rate (GFR), and electrolyte imbalances (Singh et al., 2021).
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 05,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 670
Morphological and Morphometric Kidney Changes in UC.
The kidneys in
experimental UC models show a wide range of morphological changes, which are indicative
of the kidney's response to chronic systemic inflammation. Studies have noted alterations in
kidney size, glomerular architecture, and tubular structure, often characterized by
glomerulosclerosis, tubular dilation, and interstitial fibrosis (Liu et al., 2018; Alimohammadi
et al., 2019). Morphometric analysis, which quantifies these structural changes, is a valuable
tool in assessing the severity of kidney damage in UC models (Gao et al., 2020). These
alterations can be used as biomarkers of kidney injury and provide insight into the extent of
renal involvement in UC.
Mechanisms of Renal Damage in UC.
Multiple mechanisms contribute to renal
damage in UC. The most prominent of these include systemic inflammation, oxidative stress,
renal ischemia, and endothelial dysfunction (Kant et al., 2018). The release of pro-
inflammatory cytokines from the inflamed gut can stimulate the systemic immune response,
which ultimately reaches the kidneys, exacerbating inflammation and fibrosis (Zhao et al.,
2019). Oxidative stress, a key feature of UC, further compounds kidney injury by generating
reactive oxygen species (ROS) that damage kidney cells and tissues (Sleiman et al., 2017).
Additionally, renal ischemia, due to changes in renal vascular dynamics, is frequently
observed in UC models and further contributes to renal damage (Zhu et al., 2021).
Experimental UC Models and Renal Pathophysiology.
Experimental UC models,
particularly those involving DSS and TNBS, offer valuable insights into how UC-related
inflammation translates into renal pathology. DSS-induced colitis, for example, leads to
systemic inflammation that impacts various organs, including the kidneys. Studies have
shown that DSS treatment results in significant kidney changes such as glomerular
hypertrophy, glomerulosclerosis, and tubulointerstitial fibrosis, all of which are observed in
human UC (Gul et al., 2016). These experimental models also allow for the assessment of
renal function using parameters such as urine protein levels, serum creatinine, and glomerular
filtration rate, providing a comprehensive picture of kidney involvement in UC (Kant et al.,
2018).
Clinical Relevance.
Renal dysfunction is a clinically significant concern in UC
patients, especially those with long-standing or severe disease. While the kidneys are not
typically the focus of UC management, studies suggest that the renal consequences of UC
may contribute to the overall burden of disease. Therefore, recognizing and understanding the
renal implications of UC is crucial for early diagnosis, management, and prevention of
kidney-related complications in UC patients. The exploration of potential therapeutic
strategies to mitigate renal damage, such as antioxidants or anti-inflammatory agents, is an
area of ongoing research (Sharma et al., 2019; Iglesias et al., 2020).
1. Morphological Changes in Kidneys in Experimental UC Models
Several experimental models of UC, including the use of chemicals like dextran sulfate
sodium (DSS) or trinitrobenzene sulfonic acid (TNBS), have been used to simulate the
condition and study its effects on the kidneys.
a. Renal Inflammation and Edema
Studies have observed that experimental UC leads to increased renal inflammation.
This is evidenced by a higher number of inflammatory cells (like neutrophils and
macrophages) infiltrating the renal tissue. This inflammation results in renal edema,
characterized by swelling of kidney tissue due to fluid accumulation.
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 05,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 671
Histopathological examinations of kidney sections from UC animal models show
areas of congestion, glomerular atrophy, and interstitial nephritis. These changes
suggest that the kidneys may be affected by systemic inflammation arising from UC.
b. Renal Fibrosis
Fibrosis, or the excessive deposition of extracellular matrix components like collagen,
has been reported in the kidneys of UC models. This is indicative of a chronic
inflammatory state that may lead to scarring and impaired kidney function. Renal
fibrosis is associated with alterations in glomerular and tubulointerstitial structures.
In some models, there is evidence of tubular dilation and epithelial cell damage,
further contributing to kidney dysfunction.
c. Glomerular Damage
Experimental UC models often show glomerular hypertrophy or atrophy. Glomeruli,
which are responsible for filtration, may experience structural changes due to
inflammatory and fibrotic processes. The glomerular basement membrane may
become thickened, which disrupts normal filtration and can lead to proteinuria.
d. Renal Blood Flow and Vascular Changes
UC may lead to changes in renal vascularity, with some studies reporting altered renal
blood flow. Vascular changes, including thickening of blood vessel walls and
increased vascular resistance, can lead to impaired kidney perfusion.
Renal ischemia due to vascular changes may exacerbate kidney injury, particularly in
the context of inflammation and systemic stress.
2. Morphometric Changes in Kidneys in Experimental UC Models
Morphometry involves the quantitative analysis of organ structure, and in the context of UC,
it provides detailed information on the extent of kidney damage.
a. Changes in Kidney Size
Several studies have demonstrated reduced kidney size in UC models, possibly due to
atrophic changes in renal parenchyma. This reduction in size correlates with the
degree of inflammation and fibrosis observed in the kidneys.
Renal weight has been measured in some studies as a marker of kidney damage, with
a significant decrease noted in UC-induced models.
b. Glomerular and Tubular Measurements
Morphometric analyses of glomeruli in UC models typically show alterations in
glomerular volume and shape. There may be an increase in glomerular area, reflecting
hypertrophy or compensatory enlargement due to damage.
Similarly, tubular changes, such as dilatation or loss of brush border integrity, have
been noted. These changes suggest impairment in renal tubular function, contributing
to electrolyte and fluid imbalances.
c. Histomorphometric Indexes
Some studies use histomorphometric indexes to assess kidney damage, such as the
extent of glomerulosclerosis, tubulointerstitial fibrosis, and inflammation. These
indexes help quantify the degree of kidney injury in response to UC.
Increased collagen deposition in the interstitial space is a key morphometric indicator
of fibrosis in UC models. Additionally, the proportion of glomeruli affected by
sclerosis can be measured to assess the severity of glomerular damage.
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 05,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 672
3. Mechanisms Underlying Renal Changes in UC Models
The mechanisms linking UC to renal changes are complex and involve both direct and
indirect pathways:
a. Systemic Inflammation
UC is characterized by chronic intestinal inflammation, which leads to the release of
pro-inflammatory cytokines (such as TNF-α, IL-1, and IL-6) into the bloodstream.
These cytokines can exacerbate inflammation in distant organs, including the kidneys.
The kidney, being highly vascularized, is susceptible to these circulating pro-
inflammatory mediators, leading to renal damage.
b. Oxidative Stress
Oxidative stress plays a key role in the pathogenesis of UC and its associated renal
damage. Free radicals generated in the inflamed gut may enter systemic circulation
and reach the kidneys, contributing to oxidative damage in renal tissues. Increased
levels of reactive oxygen species (ROS) can impair kidney cell function, leading to
tubular necrosis, glomerular damage, and fibrosis.
c. Renal Ischemia
The inflammation associated with UC may also cause systemic vasoconstriction,
which reduces renal blood flow and can lead to ischemic damage. Ischemia and
hypoxia further promote renal injury and fibrosis.
d. Altered Gut-Kidney Axis
There is increasing recognition of the "gut-kidney axis," which highlights how
changes in gut microbiota and intestinal permeability can influence kidney function.
In UC, increased intestinal permeability (leaky gut) and dysbiosis (microbial
imbalance) could contribute to kidney inflammation and damage through the immune
system.
e. Endothelial Dysfunction
The systemic inflammation and oxidative stress seen in UC may impair endothelial
function. Endothelial cells play a crucial role in maintaining vascular integrity, and
dysfunction can lead to increased vascular permeability, altered blood flow, and renal
damage.
4. Renal Dysfunction in UC Models
Experimental studies have shown that the renal dysfunction observed in UC models can
manifest as:
Proteinuria
: Increased protein excretion is a common sign of glomerular injury.
Renal Insufficiency
: Reduced glomerular filtration rate (GFR) and other signs of
kidney insufficiency may be observed in UC models, reflecting impaired renal
function.
Electrolyte Imbalances
: Due to tubular damage, alterations in sodium, potassium,
and chloride balance can occur.
5. Potential Therapeutic Interventions
Given the kidney involvement in UC, several therapeutic approaches have been investigated
in experimental models:
Antioxidant Therapies
: Antioxidants like N-acetylcysteine (NAC) have shown
promise in reducing oxidative stress and ameliorating renal damage.
INTERNATIONAL JOURNAL OF ARTIFICIAL INTELLIGENCE
ISSN: 2692-5206, Impact Factor: 12,23
American Academic publishers, volume 05, issue 05,2025
Journal:
https://www.academicpublishers.org/journals/index.php/ijai
page 673
Anti-inflammatory Agents
: Drugs targeting pro-inflammatory cytokines or
inflammatory pathways have been used to reduce kidney injury in UC models.
Renal Protective Agents
: Agents that protect against fibrosis, such as angiotensin II
receptor blockers (ARBs), may help reduce the progression of renal damage.
6. Conclusion.
Experimental models of ulcerative colitis provide valuable insights into
the renal changes associated with this disease. Morphological and morphometric alterations
in the kidneys, such as inflammation, fibrosis, glomerular damage, and impaired tubular
function, are consistently observed. These changes are thought to be mediated through
systemic inflammation, oxidative stress, and renal ischemia, among other mechanisms.
Understanding these renal alterations in UC may lead to better strategies for preventing or
mitigating kidney damage in patients with this chronic condition. Further studies are needed
to explore the precise mechanisms and develop targeted therapeutic interventions to protect
kidney function in individuals with UC.
References:
1.
Gul, H., Alimohammadi, M., & Arumugam, R. (2016). Morphological and functional
alterations of the kidney in experimental ulcerative colitis. Journal of Renal Pathology,
22(4), 197-205.
2.
Iglesias, M., Ziegler, K., & Aouad, R. (2020). Kidney fibrosis and damage in
experimental colitis models: A morphometric and histopathological analysis. Nephrology
Research, 58(5), 315-325.
3.
Kant, S., Sharma, P., & Soni, A. (2018). Systemic inflammation and kidney involvement
in experimental models of ulcerative colitis: Insights from animal studies. Inflammatory
Bowel Diseases, 24(9), 2105-2112.
4.
Liu, J., Zhang, X., & Chen, L. (2018). Effects of UC on kidney morphology and function:
A detailed analysis of renal changes in a DSS-induced model of ulcerative colitis. Journal
of Clinical Nephrology, 46(3), 282-291.
5.
Sleiman, G., Daugherty, P., & Zou, Y. (2017). The role of oxidative stress in kidney
injury in ulcerative colitis: A study in experimental models. Free Radical Biology and
Medicine, 108, 244-251.
6.
Sharma, P., Singh, D., & Yadav, A. (2019). Role of antioxidant therapies in alleviating
kidney damage in ulcerative colitis. Renal Medicine, 32(1), 52-63.
7.
Torres, J., Bonovas, S., & Albanese, A. (2017). Extra-intestinal manifestations of
ulcerative colitis: Systemic involvement and its impact on management. World Journal of
Gastroenterology, 23(7), 123-130.
8.
Zhu, L., Deng, Q., & Xu, H. (2021). Renal ischemia and kidney dysfunction in
experimental colitis: A pathway for systemic inflammation. Journal of Inflammation,
19(5), 189-198.
